Actylis
Actylis, a leading global supplier of specialty chemicals and raw materials, is headquartered in the United States, with significant operations across Europe and Asia. Founded in 2020, the company has quickly established itself in the chemical industry, focusing on providing high-quality products and innovative solutions for various sectors, including pharmaceuticals, food, and personal care. Actylis offers a diverse range of core products, including excipients, active pharmaceutical ingredients (APIs), and custom manufacturing services. What sets Actylis apart is its commitment to quality and sustainability, ensuring that all products meet stringent regulatory standards while minimising environmental impact. With a strong market position and a reputation for excellence, Actylis continues to achieve notable milestones, solidifying its role as a trusted partner in the global supply chain.
DitchCarbon Score
How does Actylis's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Actylis's score of 17 is higher than 90% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Actylis's reported carbon emissions
In 2023, Actylis reported total carbon emissions of approximately 1,087,000 kg CO2e from Scope 2 and about 812,000 kg CO2e from Scope 1, resulting in a combined total of around 1,899,000 kg CO2e. This marks a significant reduction from 2022, where their total emissions were approximately 3,908,000 kg CO2e, indicating a decrease of about 2,009,000 kg CO2e. Actylis has committed to achieving net-zero emissions across all scopes by 2050, with their targets aligned with the Science Based Targets initiative (SBTi). Their near-term targets are currently classified as "Committed," reflecting their dedication to reducing greenhouse gas emissions from company operations, specifically in Scopes 1 and 2. This commitment underscores Actylis's proactive approach to addressing climate change within the pharmaceuticals, biotechnology, and life sciences sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 1,507,000 | 000,000 |
| Scope 2 | 2,401,000 | 0,000,000 |
| Scope 3 | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Actylis is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
